2XRA
crystal structure of the HK20 Fab in complex with a gp41 mimetic 5- Helix
2XRA の概要
| エントリーDOI | 10.2210/pdb2xra/pdb |
| 関連するPDBエントリー | 1AIK 1DF4 1DF5 1DLB 1G9M 1GC1 1GZL 1K33 1K34 1MZI 1OPN 1OPT 1OPW 1RZJ 2CMR |
| 分子名称 | TRANSMEMBRANE PROTEIN GP41, HK20, HUMAN MONOCLONAL ANTIBODY HEAVY CHAIN, HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN, ... (4 entities in total) |
| 機能のキーワード | immune system, antibody, monoclonal cells, neutralization tests |
| 由来する生物種 | SYNTHETIC CONSTRUCT 詳細 |
| 細胞内の位置 | Surface protein gp120: Virion membrane ; Peripheral membrane protein . Transmembrane protein gp41: Virion membrane ; Single-pass type I membrane protein : P04578 |
| タンパク質・核酸の鎖数 | 3 |
| 化学式量合計 | 72961.45 |
| 構造登録者 | Sabin, C.,Corti, D.,Buzon, V.,Seaman, M.S.,Lutje Hulsik, D.,Hinz, A.,Vanzetta, F.,Agatic, G.,Silacci, C.,Langedijk, J.P.M.,Mainetti, L.,Scarlatti, G.,Sallusto, F.,Weiss, R.,Lanzavecchia, A.,Weissenhorn, W. (登録日: 2010-09-13, 公開日: 2010-12-15, 最終更新日: 2024-10-23) |
| 主引用文献 | Sabin, C.,Corti, D.,Buzon, V.,Seaman, M.S.,Lutje Hulsik, D.,Hinz, A.,Vanzetta, F.,Agatic, G.,Silacci, C.,Mainetti, L.,Scarlatti, G.,Sallusto, F.,Weiss, R.,Lanzavecchia, A.,Weissenhorn, W. Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41. PLoS Pathog., 6:e1001195-e1001195, 2010 Cited by PubMed Abstract: The human monoclonal antibody (mAb) HK20 neutralizes a broad spectrum of primary HIV-1 isolates by targeting the highly conserved heptad repeat 1 (HR1) of gp41, which is transiently exposed during HIV-1 entry. Here we present the crystal structure of the HK20 Fab in complex with a gp41 mimetic 5-Helix at 2.3 Å resolution. HK20 employs its heavy chain CDR H2 and H3 loops to bind into a conserved hydrophobic HR1 pocket that is occupied by HR2 residues in the gp41 post fusion conformation. Compared to the previously described HR1-specific mAb D5, HK20 approaches its epitope with a different angle which might favor epitope access and thus contribute to its higher neutralization breadth and potency. Comparison of the neutralization activities of HK20 IgG, Fab and scFv employing both single cycle and multiple cycle neutralization assays revealed much higher potencies for the smaller Fab and scFv over IgG, implying that the target site is difficult to access for complete antibodies. Nevertheless, two thirds of sera from HIV-1 infected individuals contain significant titers of HK20-inhibiting antibodies. The breadth of neutralization of primary isolates across all clades, the higher potencies for C-clade viruses and the targeting of a distinct site as compared to the fusion inhibitor T-20 demonstrate the potential of HK20 scFv as a therapeutic tool. PubMed: 21124990DOI: 10.1371/journal.ppat.1001195 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (2.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






